Glaucoma Division, Jules Stein Eye Institute, David Geffen School of Medicine, University of California Los Angeles, CA.
J Glaucoma. 2013 Jan;22(1):52-9. doi: 10.1097/IJG.0b013e31821e8607.
To compare intraocular pressure (IOP) reduction after trabeculectomy with mitomycin C (MMC) in eyes that had prior clear-corneal phacoemulsification to those in a control group of phakic eyes.
Thirty-nine pseudophakic eyes (38 patients) that underwent initial trabeculectomy with MMC after clear-corneal phacoemulsification between 1997 and 2009 at an academic center were matched on surgeon, age, race, and time of surgery to 39 phakic eyes (39 patients) that underwent the same intervention. Surgical success was defined as: (A) IOP ≤18 mm Hg and ≥20% reduction of IOP, (B) IOP ≤15 mm Hg and ≥25% reduction of IOP, and (C) IOP ≤12 mm Hg and ≥30% reduction of IOP, with or without glaucoma medication. The main outcome measures were success rates, IOP, and number of medications at 1 and 2 years.
The median (range) follow-up time was 36 months (1 to 109 mo) and 38 months (1 to 99 mo) in the pseudophakic and phakic groups, respectively. Success rates were not different between the 2 groups (P=0.17, 0.14, and 0.09 for criteria A, B, and C, respectively). The mean (±SD) preoperative IOP was 21.4±5.9 and 18.6±5.5 mm Hg in the pseudophakic and phakic groups, respectively (P=0.034). IOP decreased by 9.3±5.6 mm Hg versus 5.7±6.9 mm Hg at first year (P=0.057) and by 11.0±7.4 mm Hg versus 5.5±5.5 mm Hg 2 years after surgery (P=0.008). The number of medications was similar at both follow-up intervals in the 2 groups (P=0.980 and 0.679).
Results of initial trabeculectomy with MMC in eyes with prior clear-corneal phacoemulsification are comparable with those in phakic eyes. Clear-corneal phacoemulsification does not seem to affect the success rate of subsequent trabeculectomy with MMC.
比较在有透明角膜超声乳化术史的眼前房人工晶状体眼与无透明角膜超声乳化术史的眼前房人工晶状体眼施行小梁切除术联合丝裂霉素 C(MMC)后的眼压(IOP)降低情况。
在学术中心,于 1997 年至 2009 年间行透明角膜超声乳化术联合小梁切除术联合 MMC 治疗的 39 只(38 例)假晶状体眼(38 例患者)与行相同干预措施的 39 只(39 例患者)无晶状体眼进行配对,比较两组的手术成功率。手术成功定义为:(A)IOP≤18mmHg 且 IOP 降低≥20%,(B)IOP≤15mmHg 且 IOP 降低≥25%,(C)IOP≤12mmHg 且 IOP 降低≥30%,无论是否使用青光眼药物。主要观察指标为 1 年和 2 年时的成功率、IOP 和药物使用数量。
假晶状体眼和无晶状体眼的中位(范围)随访时间分别为 36 个月(1 至 109mo)和 38 个月(1 至 99mo)。两组的成功率无差异(P=0.17、0.14 和 0.09,分别为 A、B 和 C 标准)。假晶状体眼和无晶状体眼术前 IOP 均值(±SD)分别为 21.4±5.9mmHg 和 18.6±5.5mmHg(P=0.034)。术后第 1 年时,IOP 分别降低 9.3±5.6mmHg 和 5.7±6.9mmHg(P=0.057),术后第 2 年时,IOP 分别降低 11.0±7.4mmHg 和 5.5±5.5mmHg(P=0.008)。两组在两个随访间隔的药物使用数量均相似(P=0.980 和 0.679)。
在有透明角膜超声乳化术史的眼前房人工晶状体眼中施行小梁切除术联合 MMC 的结果与无透明角膜超声乳化术史的眼前房人工晶状体眼相似。透明角膜超声乳化术似乎不会影响随后行小梁切除术联合 MMC 的成功率。